Viral vectors for malaria vaccine development.

Viral vectors for malaria vaccine development.

A workshop on viral vectors for malaria vaccine development, organized by the PATH Malaria Vaccine Initiative, was held in Bethesda, MD on October 20, 2005. Recent advancements in viral-vectored malaria vaccine development and emerging vector technologies were presented and discussed. Classic viral...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Li, S, Locke, E, Bruder, J, Clarke, D, Doolan, D, Havenga, M, Hill, A, Liljestrom, P, Monath, T, Naim, H, Ockenhouse, C, Tang, D, Van Kampen, K, Viret, J, Zavala, F, Dubovsky, F
Format:	Journal article
Sprache:	English
Veröffentlicht:	2007

Ähnliche Einträge

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
von: Milicic, A, et al.
Veröffentlicht: (2017)

Viral vector vaccines make memory T cells against malaria.
von: Reyes-Sandoval, A, et al.
Veröffentlicht: (2007)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
von: Ewer, K, et al.
Veröffentlicht: (2015)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
von: Elias, S, et al.
Veröffentlicht: (2014)

Adeno‐associated viral vectored delivery of a monoclonal antibody gene against blood‐stage malaria
von: Bardelli, M, et al.
Veröffentlicht: (2019)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
von: Forbes, E
Veröffentlicht: (2011)

Viral paratransgenesis in the malaria vector Anopheles gambiae.
von: Xiaoxia Ren, et al.
Veröffentlicht: (2008-08-01)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
von: Venkatraman, N, et al.
Veröffentlicht: (2017)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
von: Elias, S, et al.
Veröffentlicht: (2013)

Acquired immunity to malaria.
von: Doolan, D, et al.
Veröffentlicht: (2009)

Viral vector vaccines
von: McCann, N, et al.
Veröffentlicht: (2022)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
von: Kapulu, MC
Veröffentlicht: (2014)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
von: Forbes, E, et al.
Veröffentlicht: (2011)

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials.
von: Berthoud, T, et al.
Veröffentlicht: (2009)

Effective induction of high-titer antibodies by viral vector vaccines.
von: Draper, S, et al.
Veröffentlicht: (2008)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
von: Pearson, FE
Veröffentlicht: (2011)

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
von: Nébié, I, et al.
Veröffentlicht: (2014)

New vectored vaccines for malaria.
von: Hill, A, et al.
Veröffentlicht: (2008)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
von: Bliss, C, et al.
Veröffentlicht: (2018)

Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants
von: Bliss, C, et al.
Veröffentlicht: (2016)

Viral vectors as vaccine platforms: Deployment in sight
von: Rollier, C, et al.
Veröffentlicht: (2011)

Viral vectors as vaccine platforms: deployment in sight.
von: Rollier, C, et al.
Veröffentlicht: (2011)

Novel Adenovirus Vector-Based Vaccines for HIV
von: Letvin N, et al.
Veröffentlicht: (2005-12-01)

Resurgent and delayed malaria
von: Greenwood, B, et al.
Veröffentlicht: (2022)

A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies
von: Yenni Yusuf, et al.
Veröffentlicht: (2019-10-01)

Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection
von: Komi Gbedande, et al.
Veröffentlicht: (2024-12-01)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
von: Ewer (nee Russell), K, et al.
Veröffentlicht: (2018)

Adeno-associated viral vectored delivery of a novel monoclonal antibody gene against blood-stage Plasmodium falciparum malaria
von: Bardelli, M, et al.
Veröffentlicht: (2018)

T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against Hepatitis C virus in non-human primates
von: Rollier, C, et al.
Veröffentlicht: (2016)

Malaria vectors of Timor-Leste
von: Frances Stephen P, et al.
Veröffentlicht: (2010-02-01)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
von: Vuola, J, et al.
Veröffentlicht: (2005)

Correction for nebie et Al., assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
von: Nébié, I, et al.
Veröffentlicht: (2014)

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
von: Hodgson, S, et al.
Veröffentlicht: (2014)

Viral vectors as vaccine platforms: from immunogenicity to impact
von: Ewer (nee Russell), K, et al.
Veröffentlicht: (2016)

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines.
von: Laurens, M, et al.
Veröffentlicht: (2012)

A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines
von: Laurens, M, et al.
Veröffentlicht: (2012)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
von: Kapulu, M, et al.
Veröffentlicht: (2010)

A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
von: Anna L Goodman, et al.
Veröffentlicht: (2011-01-01)

Plasmodium falciparum CS protein - prime malaria vaccine candidate: definition of the human CTL domain and analysis of its variation
von: Denise L. Doolan, et al.
Veröffentlicht: (1992-01-01)

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
von: Silk, SE, et al.
Veröffentlicht: (2023)